Skip to main content

Advertisement

Log in

Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Hypoparathyroidism (hypoPT) results in an impairment of quality of life (QoL), an increase in fatigue and a higher risk of mortality. Cardiovascular autonomic neuropathy (CAN) is an impairment of the cardiovascular autonomic system and is associated with increased mortality and fatigability. Patients with hypoPT show an increased risk of CAN. However, no previous studies have investigated the association between CAN and QoL in hypoPT. To test whether CAN is associated with fatigue and impaired QOL in hypoPT patients.

Methods

We enrolled 48 subjects with postsurgical hypoPT treated with calcium and calcitriol and 38 healthy subjects who underwent thyroidectomy. Subjects completed the RAND 36-Item Short Form (SF-36) Health Survey, evaluating physical (PCS) and mental (MCS) health, and fatigue score. CAN was assessed using cardiovascular autonomic reflex tests (CARTs). Participants were considered to have “early CAN” (EC) if they had one abnormal CART and “definite CAN” (DC) with two or more abnormal CARTs.

Results

Compared with controls, hypoPT population had lower fatigue scores (44.5 IQRː9 vs 38.5 IQRː12.3, P = 0.031). In the hypoPT group, only participants with DC had a lower fatigue score than subjects without CAN (DC: β: −9.55, P = 0.005) after adjusting for age, duration of disease, calcium concentration, TSH, calcitriol and calcium supplementation. No differences were found in the PCS and MCS scores in the hypoPT group.

Conclusions

CAN may explain fatigue, a common complaint of postsurgical hypoPT patients. Further larger and prospective investigations are needed to confirm our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. T. Sikjaer, E. Moser, L. Rolighed, L. Underbjerg, L.S. Bislev, L. Mosekilde, L. Rejnmark, Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism. J. Bone Miner. Res. 31, 1440–1448 (2016). https://doi.org/10.1002/jbmr.2812

    Article  PubMed  Google Scholar 

  2. D.M. Shoback, J.P. Bilezikian, A.G. Costa, D. Dempster, H. Dralle, A.A. Khan, M. Peacock, M. Raffaelli, B.C. Silva, R.V. Thakker, T. Vokes, R. Bouillon, Presentation of hypoparathyroidism: etiologies and clinical features. J. Clin. Endocrinol. Metabol. 101, 2300–2312 (2016). https://doi.org/10.1210/jc.2015-3909

    Article  CAS  Google Scholar 

  3. T.J. Vokes, Quality of life in hypoparathyroidism. Endocrinol. Metabol. Clin. North Am. 47, 855–864 (2018). https://doi.org/10.1016/j.ecl.2018.07.010

    Article  Google Scholar 

  4. M. Almquist, K. Ivarsson, E. Nordenström, A. Bergenfelz, Mortality in patients with permanent hypoparathyroidism after total thyroidectomy. Br. J. Surg. (2018). https://doi.org/10.1002/bjs.10843

    Article  CAS  Google Scholar 

  5. R. Pop-Busui, What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J. Cardiovasc. Transl. Res. 5, 463–478 (2013). https://doi.org/10.1007/s12265-012-9367-6

    Article  Google Scholar 

  6. G. Tabacco, A.M. Naciu, D. Maggi, A. Santonati, C. Pedone, R. Cesareo, D. Bosco, G. Gaspa, N. Napoli, P. Pozzilli, S. Manfrini, A. Palermo, Cardiovascular autonomic neuropathy as a new complication of postsurgical chronic hypoparathyroidism. J. Bone Miner. Res. 34, 475–481 (2019). https://doi.org/10.1002/jbmr.3623

    Article  CAS  PubMed  Google Scholar 

  7. C. Cardone, I test che valutano la risposta riflessa cardiovascolare. Neuropatia diabetica. Rass. Bibliogr. 2, 151–160 (1990)

    Google Scholar 

  8. V. Spallone, D. Ziegler, R. Freeman, L. Bernardi, S. Frontoni, R. Pop-Busui, M. Stevens, P. Kempler, J. Hilsted, S. Tesfaye, P. Low, P. Valensi, Toronto consensus panel on diabetic neuropathy, cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metabol. Res. Rev. 27, 639–653 (2011). https://doi.org/10.1002/dmrr.1239

    Article  Google Scholar 

  9. J.E. Ware, C.D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30, 473–83 (1992). http://www.ncbi.nlm.nih.gov/pubmed/1593914 (Accessed 13 Feb 2018)

  10. K. Webster, D. Cella, K. Yost, The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual. Life Outcomes 1, 79 (2003). https://doi.org/10.1186/1477-7525-1-79

    Article  PubMed  PubMed Central  Google Scholar 

  11. M.T. James, J. Zhang, A.W. Lyon, B.R. Hemmelgarn, Derivation and internal validation of an equation for albumin-adjusted calcium. BMC Clin. Pathol. 8, 12 (2008). https://doi.org/10.1186/1472-6890-8-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. M. Büttner, T.J. Musholt, S. Singer, Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine 58, 14–20 (2017). https://doi.org/10.1007/s12020-017-1377-3

    Article  CAS  PubMed  Google Scholar 

  13. A. Santonati, A. Palermo, E. Maddaloni, D. Bosco, A. Spada, F. Grimaldi, B. Raggiunti, R. Volpe, S. Manfrini, F. Vescini, PTH(1-34) for surgical hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life. J. Clin. Endocrinol. Metabol. 100, 3590–3597 (2015). https://doi.org/10.1210/jc.2015-1855

    Article  CAS  Google Scholar 

  14. A. Palermo, A. Santonati, G. Tabacco, D. Bosco, A. Spada, C. Pedone, B. Raggiunti, T. Doris, D. Maggi, F. Grimaldi, S. Manfrini, F. Vescini, PTH(1–34) for surgical hypoparathyroidism: a 2-year prospective, open-label investigation of efficacy and quality of life. J. Clin. Endocrinol. Metabol. 103, 271–280 (2018). https://doi.org/10.1210/jc.2017-01555

    Article  Google Scholar 

  15. N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, L. Anderson, E. Levy, J.P. Bilezikian, PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J. Clin. Endocrinol. Metabol. 99, 3694–3699 (2014). https://doi.org/10.1210/jc.2014-2267

    Article  CAS  Google Scholar 

  16. N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, A. Tulley, J. Sliney, J.P. Bilezikian, The effect of PTH(1-84) on quality of life in hypoparathyroidism. J. Clin. Endocrinol. Metabol. 98, 2356–2361 (2013). https://doi.org/10.1210/jc.2013-1239

    Article  CAS  Google Scholar 

  17. V.A. Serhiyenko, A.A. Serhiyenko, Cardiac autonomic neuropathy: risk factors, diagnosis and treatment. World J. Diabetes 9, 1–24 (2018). https://doi.org/10.4239/wjd.v9.i1.1

    Article  PubMed  PubMed Central  Google Scholar 

  18. T. Nakamura, M. Hirayama, T. Hara, T. Hama, H. Watanabe, G. Sobue, Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson’s disease? Mov. Disord. 26, 1869–1874 (2011). https://doi.org/10.1002/mds.23744

    Article  PubMed  Google Scholar 

  19. S. Merkelbach, U. Dillmann, C. Ko, È. Lmel, J. Holz, M. Mu, È. Ller, Cardiovascular autonomic dysregulation and fatigue in multiple sclerosis. Mult. Scelerosis. 7, 320–326 (2011). http://journals.sagepub.com/doi/pdf/10.1177/135245850100700508 (Accessed 18 Apr 2018)

    Article  CAS  Google Scholar 

  20. J.L. Newton, O. Okonkwo, K. Sutcliffe, A. Seth, J. Shin, D.E.J. Jones, Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM 100, 519–26 (2007). https://doi.org/10.1093/qjmed/hcm057

    Article  CAS  PubMed  Google Scholar 

  21. R. Freeman, A.L. Komaroff, Does the chronic fatigue syndrome involve the autonomic nervous system? Am. J. Med. 102, 357–64 (1997). http://www.ncbi.nlm.nih.gov/pubmed/9217617 (Accessed 13 Dec 2018)

    Article  CAS  Google Scholar 

  22. T.J. Vokes, M. Mannstadt, M.A. Levine, B.L. Clarke, P. Lakatos, K. Chen, R. Piccolo, A. Krasner, D.M. Shoback, J.P. Bilezikian, Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism. J. Clin. Endocrinol. Metabol. 103, 722–731 (2018). https://doi.org/10.1210/jc.2017-01471

    Article  Google Scholar 

  23. G. Tabacco, Y.-K.D. Tay, N.E. Cusano, J. Williams, B. Omeragic, R. Majeed, M.G. Almonte, M.R. Rubin, J.P. Bilezikian, Quality of life in hypoparathyroidism improves with rhPTH(1-84) throughout 8 years of therapy. J. Clin. Endocrinol. Metabol. (2019). https://doi.org/10.1210/jc.2018-02430

Download references

Authors' contributions

Study design: GT, AP. Study conduct: GT, AMN, AMDT, PP, SM, and AP. Data collection: GT, AMN, AMDT, DM, AS, RC, DB, and AP. Data analysis: CP and DL. Data interpretation: GT, AMN, CP, DL, and AP. Drafting manuscript: GT, AMN, and AP. Revising manuscript content: GT, AMN, AMDT, DM, AS, RC, DB, PP, SM, and AP. Approving final version of manuscript: GT, AMN, DM, AMDT, AS, RC, DB, GG, PP, SM, and AP. GT, AMN, and AP take responsibility for the integrity of the data analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Palermo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study was conducted in compliance with the Declaration of Helsinki and its later amendments or comparable ethical standards. The research protocol was approved by the Ethics Committee at the University Campus Bio-Medico of Rome.

Informed consent

Informed consent was obtained from all individual included in the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tabacco, G., Naciu, A.M., Cesareo, R. et al. Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism. Endocrine 67, 198–203 (2020). https://doi.org/10.1007/s12020-019-02101-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-019-02101-w

Keywords

Navigation